News

August 23, 2017August 23, 2017

Synergy, MDA Jointly Develop Guide for Muscular Dystrophy Patients and Caregivers

Synergy HomeCare and the nonprofit Muscular Dystrophy Association (MDA) have teamed up in a national partnership to improve quality of life and give more independence to people with neuromuscular disorders. The ... Read more

August 21, 2017August 21, 2017

Choice of Surgery to Correct Foot Deformities in MD Disease Subtype Varies Greatly, Study Shows

News

Many patients with Charcot-Marie-Tooth (CMT) disease, a subtype of muscular dystrophy, undergo surgeries to correct foot deformities. Yet a new study finds that surgeons vary significantly in their choice of procedures for ... Read more

August 18, 2017August 18, 2017

Capricor Therapeutics Issues Progress Report on Its Cardiac Cell Therapy CAP-1002 for DMD

News

Capricor Therapeutics recently shared an update of the company’s quarterly financial results and operational highlights, including positive results for the ongoing HOPE study with Duchenne muscular dystrophy (DMD) patients. The Phase I/II HOPE study ... Read more

August 16, 2017

Heart Association Awards Grant to University Scientist for Development of New Duchenne Therapies

News

The American Heart Association (AHA) has awarded its distinguished Scientist Development Grant to a University at Albany researcher for the development of new therapies to treat Duchenne muscular dystrophy (DMD). ... Read more

August 14, 2017

Researchers Develop Newborn Screening Tool for Duchenne

News

Cardiff University scientists, partnering with the biotech company PerkinElmer, have developed a diagnostic kit to screen for Duchenne muscular dystrophy (DMD) in newborns using dried blood spots, according to researchers. The ... Read more

August 11, 2017August 11, 2017

Mitobridge’s Investigational DMD Therapy MA-0211 to Be Tested in Healthy Volunteers in Initial Clinical Trial

News

The investigational therapy MA-0211, also called MTB-1, a potential treatment for Duchenne Muscular Dystrophy (DMD), was approved for a Phase I clinical trial, developer Mitobridge announced. The trial will evaluate ... Read more

August 10, 2017August 12, 2017

Phase 2 Trial of Muscle Therapy ACE-083 for Charcot-Marie-Tooth Disease Doses 1st Patient

News

The first patient has been dosed in a Phase 2 clinical trial of ACE-083 as a treatment for the muscle impairment in Charcot-Marie-Tooth disease, according to the therapy’s developer, Acceleron Pharma. Acceleron ... Read more

August 7, 2017

Casey’s General Stores Partners with MDA to Send Kids with Muscular Dystrophy to Summer Camp

News

Continuing an 11-year tradition, the Muscular Dystrophy Association (MDA) will once again team up with Casey’s General Stores in Iowa to help send children with muscular dystrophy (MD) and related diseases ... Read more

August 4, 2017

Jiffy Lube, MDA Launch 6th Annual MUSCLE UP! Campaign

News

Jiffy Lube and the Muscular Dystrophy Association (MDA) are teaming up again this summer for the 6th annual MUSCLE UP! campaign. Each August for the past five years, Jiffy ... Read more

August 2, 2017August 2, 2017

New Gene Therapy to Fix Dystrophin Deficiency in DMD Shows Promise in Mice, Study Shows

News

Researchers at the University of Missouri have developed a new method to efficiently deliver the correct form of dystrophin gene to muscles as a way to correct the faulty ... Read more